GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (XTAE:BOLT) » Definitions » Other Operating Expense

BioLight Life Sciences (XTAE:BOLT) Other Operating Expense : ₪3.86 Mil (TTM As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is BioLight Life Sciences Other Operating Expense?

BioLight Life Sciences's Other Operating Expense for the six months ended in Dec. 2024 was ₪3.86 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₪3.86 Mil.

BioLight Life Sciences's quarterly Other Operating Expense declined from Dec. 2023 (₪3.78 Mil) to Jun. 2024 (₪-0.00 Mil) but then increased from Jun. 2024 (₪-0.00 Mil) to Dec. 2024 (₪3.86 Mil).

BioLight Life Sciences's annual Other Operating Expense declined from Dec. 2022 (₪4.23 Mil) to Dec. 2023 (₪3.78 Mil) but then increased from Dec. 2023 (₪3.78 Mil) to Dec. 2024 (₪3.86 Mil).


BioLight Life Sciences Other Operating Expense Historical Data

The historical data trend for BioLight Life Sciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences Other Operating Expense Chart

BioLight Life Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.44 3.59 4.23 3.78 3.86

BioLight Life Sciences Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.23 - 3.78 - 3.86

BioLight Life Sciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪3.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLight Life Sciences Other Operating Expense Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLight Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Aba Hillel Silver 12, 11 floor, Ramat Gan, ISR, 5250606
BioLight Life Sciences Ltd is an emerging ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.